Di Beroceutica

Circa la società

Beroceutica reinvents healthcare with Artificial Intelligence. It identifies significant patterns in clinical datasets, which can be used for novel diagnostics and therapies. Beroceutica's technology monitors individual responses to drug action, using a selection of 'hot-spot' SNPs, as well as non-genetic markers. It uses machine learning algorithms like artificial neural networks to stratify patients in clinical studies. Drug actions are simulated along the biochemical pathways. The company also discovers novel, synergistic drug combinations to overcome currently unmet medical needs.